Your browser doesn't support javascript.
loading
Observational study on HIV-infected subjects failing HAART receiving tenofovir plus didanosine as NRTI backbone.
Bongiovanni, M; Gianotti, N; Chiesa, E; Nasta, P; Cicconi, P; Capetti, A; di Biagio, A; Matti, A; Tirelli, V; Marconi, P; de Luca, A; Mussini, C; Gatti, F; Zaccarelli, M; Abeli, C; Torti, C; Antinori, A; Castagna, A; d'Arminio Monforte, A.
Affiliation
  • Bongiovanni M; Clinic of Infectious Diseases and Tropical Medicine, San Paolo Hospital, University of Milan, 20142, Milano, Italy. marco.bongiovanni@unimi.it
Infection ; 35(6): 451-6, 2007 Dec.
Article in En | MEDLINE | ID: mdl-18034204
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Adenine / HIV Infections / Didanosine / Reverse Transcriptase Inhibitors / Anti-HIV Agents / Antiretroviral Therapy, Highly Active / Organophosphonates Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Infection Year: 2007 Document type: Article Affiliation country: Italy Country of publication: Germany
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Adenine / HIV Infections / Didanosine / Reverse Transcriptase Inhibitors / Anti-HIV Agents / Antiretroviral Therapy, Highly Active / Organophosphonates Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Infection Year: 2007 Document type: Article Affiliation country: Italy Country of publication: Germany